Cargando…
Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases
Beta-lactamases represent the main bacterial mechanism of resistance to beta-lactam antibiotics and are a significant challenge to modern medicine. We have developed an automated classification and analysis protocol that exploits structure- and sequence-based approaches and which allows us to propos...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917113/ https://www.ncbi.nlm.nih.gov/pubmed/27332861 http://dx.doi.org/10.1371/journal.pcbi.1004926 |
_version_ | 1782438911628279808 |
---|---|
author | Lee, David Das, Sayoni Dawson, Natalie L. Dobrijevic, Dragana Ward, John Orengo, Christine |
author_facet | Lee, David Das, Sayoni Dawson, Natalie L. Dobrijevic, Dragana Ward, John Orengo, Christine |
author_sort | Lee, David |
collection | PubMed |
description | Beta-lactamases represent the main bacterial mechanism of resistance to beta-lactam antibiotics and are a significant challenge to modern medicine. We have developed an automated classification and analysis protocol that exploits structure- and sequence-based approaches and which allows us to propose a grouping of serine beta-lactamases that more consistently captures and rationalizes the existing three classification schemes: Classes, (A, C and D, which vary in their implementation of the mechanism of action); Types (that largely reflect evolutionary distance measured by sequence similarity); and Variant groups (which largely correspond with the Bush-Jacoby clinical groups). Our analysis platform exploits a suite of in-house and public tools to identify Functional Determinants (FDs), i.e. residue sites, responsible for conferring different phenotypes between different classes, different types and different variants. We focused on Class A beta-lactamases, the most highly populated and clinically relevant class, to identify FDs implicated in the distinct phenotypes associated with different Class A Types and Variants. We show that our FunFHMMer method can separate the known beta-lactamase classes and identify those positions likely to be responsible for the different implementations of the mechanism of action in these enzymes. Two novel algorithms, ASSP and SSPA, allow detection of FD sites likely to contribute to the broadening of the substrate profiles. Using our approaches, we recognise 151 Class A types in UniProt. Finally, we used our beta-lactamase FunFams and ASSP profiles to detect 4 novel Class A types in microbiome samples. Our platforms have been validated by literature studies, in silico analysis and some targeted experimental verification. Although developed for the serine beta-lactamases they could be used to classify and analyse any diverse protein superfamily where sub-families have diverged over both long and short evolutionary timescales. |
format | Online Article Text |
id | pubmed-4917113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-49171132016-07-08 Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases Lee, David Das, Sayoni Dawson, Natalie L. Dobrijevic, Dragana Ward, John Orengo, Christine PLoS Comput Biol Research Article Beta-lactamases represent the main bacterial mechanism of resistance to beta-lactam antibiotics and are a significant challenge to modern medicine. We have developed an automated classification and analysis protocol that exploits structure- and sequence-based approaches and which allows us to propose a grouping of serine beta-lactamases that more consistently captures and rationalizes the existing three classification schemes: Classes, (A, C and D, which vary in their implementation of the mechanism of action); Types (that largely reflect evolutionary distance measured by sequence similarity); and Variant groups (which largely correspond with the Bush-Jacoby clinical groups). Our analysis platform exploits a suite of in-house and public tools to identify Functional Determinants (FDs), i.e. residue sites, responsible for conferring different phenotypes between different classes, different types and different variants. We focused on Class A beta-lactamases, the most highly populated and clinically relevant class, to identify FDs implicated in the distinct phenotypes associated with different Class A Types and Variants. We show that our FunFHMMer method can separate the known beta-lactamase classes and identify those positions likely to be responsible for the different implementations of the mechanism of action in these enzymes. Two novel algorithms, ASSP and SSPA, allow detection of FD sites likely to contribute to the broadening of the substrate profiles. Using our approaches, we recognise 151 Class A types in UniProt. Finally, we used our beta-lactamase FunFams and ASSP profiles to detect 4 novel Class A types in microbiome samples. Our platforms have been validated by literature studies, in silico analysis and some targeted experimental verification. Although developed for the serine beta-lactamases they could be used to classify and analyse any diverse protein superfamily where sub-families have diverged over both long and short evolutionary timescales. Public Library of Science 2016-06-22 /pmc/articles/PMC4917113/ /pubmed/27332861 http://dx.doi.org/10.1371/journal.pcbi.1004926 Text en © 2016 Lee et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Lee, David Das, Sayoni Dawson, Natalie L. Dobrijevic, Dragana Ward, John Orengo, Christine Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases |
title | Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases |
title_full | Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases |
title_fullStr | Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases |
title_full_unstemmed | Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases |
title_short | Novel Computational Protocols for Functionally Classifying and Characterising Serine Beta-Lactamases |
title_sort | novel computational protocols for functionally classifying and characterising serine beta-lactamases |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917113/ https://www.ncbi.nlm.nih.gov/pubmed/27332861 http://dx.doi.org/10.1371/journal.pcbi.1004926 |
work_keys_str_mv | AT leedavid novelcomputationalprotocolsforfunctionallyclassifyingandcharacterisingserinebetalactamases AT dassayoni novelcomputationalprotocolsforfunctionallyclassifyingandcharacterisingserinebetalactamases AT dawsonnataliel novelcomputationalprotocolsforfunctionallyclassifyingandcharacterisingserinebetalactamases AT dobrijevicdragana novelcomputationalprotocolsforfunctionallyclassifyingandcharacterisingserinebetalactamases AT wardjohn novelcomputationalprotocolsforfunctionallyclassifyingandcharacterisingserinebetalactamases AT orengochristine novelcomputationalprotocolsforfunctionallyclassifyingandcharacterisingserinebetalactamases |